The ligand of ILT7 has been identified as bone marrow stromal cell antigen 2 (BST2, also known as CD317) widely expressed in human tissues to varying degrees and reported in several human cancer cell lines, as well as in a wide range of tumors [143–145]. Here, LILRA4 is linked to cancer.